Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$668M |
| 2 |
Chevron
CVX
|
+$626M |
| 3 |
NVIDIA
NVDA
|
+$567M |
| 4 |
Microsoft
MSFT
|
+$538M |
| 5 |
CRH
CRH
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$599M |
| 2 |
Intel
INTC
|
+$509M |
| 3 |
Eli Lilly
LLY
|
+$240M |
| 4 |
Analog Devices
ADI
|
+$239M |
| 5 |
EOG Resources
EOG
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.61% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Financials | 10.25% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSXY
1276
Victoria's Secret
VSXY
$6.64B
| $700K | ﹤0.01% |
45,313
+43,462
| +2,348% | +$822K |
|
1277
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
| $693K | ﹤0.01% |
20,700
-1,800
| -8% | -$61.7K |
|
1278
Freshworks
FRSH
$2.84B
| $692K | ﹤0.01% |
39,009
+29,868
| +327% | +$594K |
|
1279
Ambarella
AMBA
$2.99B
| $692K | ﹤0.01% |
13,085
-1,496
| -10% | -$105K |
|
1280
HUTCHMED
HCM
$1.89B
| $689K | ﹤0.01% |
36,901
| – | – |
|
1281
Amkor Technology
AMKR
$16.1B
| $684K | ﹤0.01% |
30,034
+29,240
| +3,683% | +$771K |
|
1282
The Ensign Group
ENSG
$10.1B
| $681K | ﹤0.01% |
7,116
-178
| -2% | -$16.8K |
|
1283
REX American Resources
REX
$1.46B
| $679K | ﹤0.01% |
37,762
+4,630
| +14% | +$87.1K |
|
1284
Banco de Chile
BCH
$20.6B
| $648K | ﹤0.01% |
33,422
| – | – |
|
|
SIX
1285
DELISTED
Six Flags Entertainment Corp.
SIX
| $644K | ﹤0.01% |
+31,031
| New | +$733K |
|
|
BCPC
1286
Balchem Corp
BCPC
$5.23B
| $641K | ﹤0.01% |
5,127
+20
| +0.4% | +$2.66K |
|
1287
Cars.com
CARS
$641M
| $627K | ﹤0.01% |
38,821
+31,000
| +396% | +$606K |
|
1288
Virtus Investment Partners
VRTS
$1.11B
| $626K | ﹤0.01% |
3,446
-42
| -1% | -$8.55K |
|
|
LAZR
1289
DELISTED
Luminar Technologies
LAZR
| $623K | ﹤0.01% |
10,087
+3,923
| +64% | +$360K |
|
1290
Evertec
EVTC
$1.83B
| $619K | ﹤0.01% |
16,956
| – | – |
|
|
BRSP
1291
BrightSpire Capital
BRSP
$681M
| $614K | ﹤0.01% |
101,082
| – | – |
|
|
MRTX
1292
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $613K | ﹤0.01% |
10,958
-2,812
| -20% | -$100K |
|
1293
Teladoc Health
TDOC
$1.58B
| $613K | ﹤0.01% |
33,107
+672
| +2% | +$15.7K |
|
|
BDN
1294
Brandywine Realty Trust
BDN
$551M
| $607K | ﹤0.01% |
150,126
| – | – |
|
1295
Helmerich & Payne
HP
$3.53B
| $605K | ﹤0.01% |
+14,000
| New | +$585K |
|
|
AHRT
1296
AH Realty Trust
AHRT
$534M
| $602K | ﹤0.01% |
58,143
| – | – |
|
1297
Dole
DOLE
$1.35B
| $597K | ﹤0.01% |
55,612
| – | – |
|
|
PGRE
1298
DELISTED
Paramount Group
PGRE
| $597K | ﹤0.01% |
136,247
| – | – |
|
1299
MasTec
MTZ
$26.7B
| $594K | ﹤0.01% |
+9,314
| New | +$928K |
|
1300
Futu Holdings
FUTU
$13.9B
| $589K | ﹤0.01% |
+9,437
| New | +$503K |
|
Similar funds
Amundi's Q3 2023 Portfolio in Review
As of Q3 2023, Amundi held 2,094 positions worth $203B, up 2.9% from $198B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi deployed $11.1B of net new capital in Q3 2023, opening 69 new positions and adding to 881 existing holdings. Its largest new stake was Kenvue: 14,174,156 shares worth $275M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $599M trimmed.
- Amundi's largest Q3 2023 buy was Kenvue: 14,174,156 shares worth $275M.
- Amundi added most to UnitedHealth in Q3 2023, an estimated $668M increase.
- Amundi's biggest Q3 2023 reduction was Advanced Micro Devices, cutting an estimated $599M.
- Amundi fully exited Elanco Animal Health in Q3 2023, selling an estimated $25.3M.
- Amundi's ten largest holdings make up 23% of its $203B portfolio in Q3 2023.
- Amundi opened 69 new positions and closed 87 in Q3 2023.
- Amundi's portfolio value rose 2.9% quarter-over-quarter to $203B.
Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.